Direxion Daily S&P Biotech Bull 3X ETF
LABU
37 hedge funds and large institutions have $51.9M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 15 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 6
17% more call options, than puts
Call options by funds: $87.4M | Put options by funds: $74.5M
0.99% more ownership
Funds ownership: 5.48% → 6.47% (+0.99%)
0% more capital invested
Capital invested by funds: $51.9M → $51.9M (+$16K)
14% less funds holding
Funds holding: 43 → 37 (-6)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$13.9M |
| 2 |
Squarepoint
New York
|
+$10.9M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.66M |
| 4 |
VF
Virtu Financial
New York
|
+$3.98M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
-$9.01M |
| 2 |
TAA
TB Alternative Assets
Grand Cayman,
Cayman Islands
|
-$5.36M |
| 3 |
QC
Quadrature Capital
London,
United Kingdom
|
-$4.64M |
| 4 |
CM
Cercano Management
Bellevue,
Washington
|
-$3.7M |
| 5 |
GS
GTS Securities
New York
|
-$2.9M |
LABU Hedge Fund Activity: Q4 2024 in Review
37 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2024, worth a combined $51.9M — up 0.03% from $51.9M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of LABU and 9 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 15 added.
The largest buyer was Citadel Advisors, adding an estimated $13.9M. The largest seller was Tidal Investments, exiting entirely with an estimated $9.01M sold.
- 37 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2024, down from 43 in Q3 2024.
- Funds reported $51.9M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2024, up 0.03% quarter-over-quarter.
- 9 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2024 and 15 closed out, a net change of -6 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2024 was Citadel Advisors, an estimated $13.9M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2024 was Tidal Investments, an estimated $9.01M sold.
Based on aggregated 13F filings for Q4 2024.